Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,273 | 6,320 | 5,988 | 7,312 | 10,880 |
| Marketable Securities | 7,960 | 9,873 | 11,828 | 12,827 | 11,851 |
| Other current assets | 102 | 161 | 137 | 104 | 66 |
| TOTAL | $13,242 | $17,309 | $19,322 | $21,091 | $24,349 |
| Non-Current Assets | |||||
| PPE Net | 127 | 139 | 145 | 144 | 137 |
| Investments And Advances | 0 | 0 | 988 | 1,942 | 2,916 |
| Other Non-Current Assets | 729 | 814 | 868 | 922 | 923 |
| TOTAL | $856 | $952 | $2,001 | $3,008 | $3,976 |
| Total Assets | $14,098 | $18,261 | $21,323 | $24,099 | $28,326 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 109 | 112 | 109 | 108 | 101 |
| Accounts payable and accrued liabilities | 1,377 | 924 | 2,214 | 1,626 | 1,019 |
| Other current liabilities | 2,693 | 3,247 | 2,600 | 2,107 | 2,942 |
| TOTAL | $5,763 | $5,588 | $5,155 | $4,125 | $4,332 |
| Non-Current Liabilities | |||||
| Long Term Debt | 435 | 467 | 478 | 495 | 484 |
| Deferred Revenues | 1,354 | 1,069 | N/A | 55 | 55 |
| Other Non-Current Liabilities | 424 | 504 | 551 | 599 | 847 |
| TOTAL | $1,003 | $1,580 | $1,029 | $1,095 | $1,331 |
| Total Liabilities | $6,767 | $7,168 | $6,184 | $5,220 | $5,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,910 | 12,699 | 12,329 | 11,883 | 11,883 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -38,516 | -38,516 | -38,516 | -20,926 | -20,926 |
| Other shareholders' equity | -17,453 | -12,691 | -5,041 | -17,555 | -13,213 |
| TOTAL | $7,331 | $11,093 | $15,139 | $18,880 | $22,663 |
| Total Liabilities And Equity | $14,098 | $18,261 | $21,323 | $24,099 | $28,326 |